We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    CV9104
Previous Study | Return to List | Next Study

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

This study has been terminated.
(Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01817738
First Posted: March 25, 2013
Last Update Posted: February 17, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
CureVac AG
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)